. Author manuscript; available in PMC: 2019 Jan 1.

Published in final edited form as: Int J Obes (Lond). 2017 Aug 17;42(1):1–7. doi: 10.1038/ijo.2017.205

Table 2.

Association of overall prenatal antibiotic or antifungal use with body mass index (BMI) Z-score and child overweight/obese at age 2 year visit

	BMI Z-score		Overweight/Obese
	β (se)	P	OR (95 % CI OR)	P
Any Prenatal Antibiotic Use
Model 1	0.21 (0.10)	0.033	1.01 (0.64,1.61)	0.953
Model 2	0.20 (0.10)	0.046	1.04 (0.62, 1.74)	0.885
Any Prenatal Antifungal Use
Model 1	0.09 (0.12)	0.464	1.26 (0.72, 2.18)	0.419
Model 2	−0.13 (0.13)	0.323	0.99 (0.53, 1.87)	0.984

Model 1: Unadjusted; Model 2: adjusted for infant gender, delivery mode, ever breastfed, maternal age, maternal race, maternal education, birthweight Z-score, child age at 2-year visit and BMI at first prenatal care visit